Publications by authors named "Giulia Andreotti"
Transl Lung Cancer Res
July 2024
Article Synopsis
- Lung cancer remains the leading cause of cancer mortality, but advancements in treating non-small cell lung cancer (NSCLC) have improved patient outcomes through tailored approaches using immune checkpoint inhibitors and genetic testing.
- A study was conducted across multiple pulmonary pathology units in Northern Italy, analyzing biomarker testing data for 1,817 NSCLC patients over 24 months, finding that while most had at least one test, only 36% of advanced cases underwent all five recommended tests.
- The results emphasize the need for comprehensive biomarker testing, as many early-stage patients also exhibited relevant genomic alterations, which is important for future targeted therapies.
